Inactive Instrument

Calendar PHARMAGEST INTER. Euronext Paris

Equities

FR0000077687

End-of-day quote Euronext Paris
- EUR - Intraday chart for PHARMAGEST INTER.

Chart calendar PHARMAGEST INTER.

58d92ac42dbc8c70591a5d.ld8kJ4ZecLXt9wGWP3njZHR2xw48H-d-Db0vXRdatbk.-7dvRLUEJd-elmndUEzSCjY4lkNKV4wpQoRmGiVt2I-jlEdC4GYx3525MQ~7ac0c0ff2012d2d832b5a348cdbd4fd4

Upcoming events on PHARMAGEST INTER.

27/06/2024 08:30 pm Annual General Meeting
02/08/2024 Q2 2024 Sales and Revenue Release
27/09/2024 Q2 2024 Earnings Release
07/11/2024 Q3 2024 Sales and Revenue Release
06/02/2025 Q4 2024 Earnings Release
19/09/2025 Q2 2025 Earnings Release (Projected)
27/03/2026 Q4 2025 Earnings Release (Projected)
18/09/2026 Q2 2026 Earnings Release (Projected)
26/03/2027 Q4 2026 Earnings Release (Projected)

Past events on PHARMAGEST INTER.

Today Q1 2024 Sales and Revenue Release
29/03/2024 10:30 am Q4 2023 Earnings Release
06/02/2024 10:30 pm Q4 2023 Sales and Revenue Release
09/11/2023 10:30 pm Q3 2023 Sales and Revenue Release
02/10/2023 Q2 2023 Earnings Call
29/09/2023 09:30 pm Q2 2023 Earnings Release
03/08/2023 09:30 pm Q2 2023 Sales and Revenue Release
03/07/2023 Ex-dividend day for final dividend
29/06/2023 09:00 pm Annual General Meeting
11/05/2023 09:30 pm Q1 2023 Sales and Revenue Release
27/03/2023 03:00 pm Q4 2022 Earnings Call
24/03/2023 10:30 pm Q4 2022 Earnings Release
03/02/2023 10:30 pm FY 2022 Sales and Revenue Release
09/11/2022 10:30 pm Q3 2022 Sales and Revenue Release
23/09/2022 Interim 2022 Earnings Call
22/09/2022 09:30 pm Interim 2022 Earnings Release
03/08/2022 Interim 2022 Sales and Revenue Release
30/06/2022 Ex-dividend day for final dividend
28/06/2022 Annual General Meeting
12/05/2022 09:40 pm Q1 2022 Sales and Revenue Release

Annual results

Fiscal PeriodDecember 2018 2019 2020 2021 2022 2023
Net sales
Million EUR
Released
Forecast
Spread
148
148
-0.01%
159
0,00
-
172
172
-0.35%
193
192
0.32%
214
215
-0.35%
220
223
-1.58%
EBITDA
Million EUR
Released
Forecast
Spread
44,1
43,2
2.04%
48,8
48,0
1.64%
55,8
52,6
6.12%
62,2
61,0
1.85%
69,2
69,1
0.05%
0,00
69,0
-
EBIT
Million EUR
Released
Forecast
Spread
38,9
38,0
2.29%
40,9
42,3
-3.43%
46,7
45,3
2.9%
50,3
51,7
-2.87%
55,2
56,3
-1.88%
55,8
55,1
1.2%
Earnings before Tax (EBT)
Million EUR
Released
Forecast
Spread
39,9
39,0
2.29%
0,00
0,00
-
0,00
0,00
-
51,9
52,6
-1.43%
54,4
56,6
-3.83%
0,00
55,6
-
Net income
Million EUR
Released
Forecast
Spread
25,4
25,6
-0.73%
28,4
28,7
-1.05%
30,7
31,8
-3.45%
39,1
37,8
3.39%
46,4
44,9
3.3%
47,0
45,9
2.45%
EPS
EUR
Released
Forecast
Spread
1,68
1,73
-2.66%
1,87
1,89
-1.06%
2,04
2,13
-4.28%
2,60
2,43
6.98%
3,09
2,93
5.62%
3,13
3,07
2.03%
Announcement Date29/03/1901/04/2026/03/2125/03/2228/04/2329/03/24

Quarterly results

Fiscal PeriodDecember 2019 S1 2021 Q3 2021 Q4 2022 S1 2022 Q4 2023 Q3 2023 Q4 2024 Q1
Net sales
Million EUR
Released
Forecast
Spread
76,9
77,9
-1.31%
44,2


55,0
54,9
0.11%
104
104
-0.03%

61,9

50,1
53,8
-6.88%

59,8


56,0

EBIT
Million EUR
Released
Forecast
Spread
18,7
20,5
-9.02%






25,8
26,9
-4.24%












Announcement Date02/08/1925/12/2125/03/2222/09/22-09/11/23--
  1. Stock Market
  2. Equities
  3. EQS Stock
  4. Stock
  5. Calendar PHARMAGEST INTER.
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW